Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
Anna I Guerdjikova,1,2 Nicole Mori,1,2 Leah S Casuto,1,2 Susan L McElroy1,2 1Lindner Center of HOPE, Mason, OH, USA; 2Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA Abstract: Binge eating disorder (BED) is the most common eat...
Saved in:
| Main Authors: | Guerdjikova AI, Mori N, Casuto LS, McElroy S |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-04-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/novel-pharmacologic-treatment-in-acute-binge-eating-disorder-ndash-rol-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
by: Fornaro M, et al.
Published: (2016-07-01) -
New CuO nanocomposite as non-enzymatic glucose biosensor
by: Mojtaba Ghorbani, et al.
Published: (2025-04-01) -
Relationship between psychopathology and binge size in binge eating spectrum disorders
by: Carla L. Mourilhe Silva, et al.
Published: (2024-12-01) -
Psychosocial factors of binge-eating: a meta-analytical study
by: A. A. Lifintseva, et al.
Published: (2019-10-01) -
Binge eating disorder: epidemiological, clinical, pathophysiological, and treatment aspects
by: E. G. Starostina, et al.
Published: (2024-03-01)